迦南科技(300412) - 2021 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2021 was CNY 320,423,944, representing a year-on-year increase of 19.72%[3] - Net profit attributable to shareholders decreased by 16.14% to CNY 20,068,363.16 in Q3 2021[3] - The basic earnings per share for Q3 2021 was CNY 0.08, down 11.11% compared to the same period last year[3] - Total operating revenue for Q3 2021 reached CNY 752.36 million, an increase of 24.5% compared to CNY 604.29 million in Q3 2020[24] - Net profit for Q3 2021 was CNY 70.71 million, representing a 30.6% increase from CNY 54.15 million in Q3 2020[25] - The basic earnings per share of CNY 0.22, compared to CNY 0.20 in the same quarter last year, reflecting a 10% increase[26] Assets and Liabilities - The company's total assets at the end of the reporting period were CNY 1,932,817,552.55, a 9.94% increase from the previous year[4] - The company's total assets increased to CNY 1.93 billion, up from CNY 1.76 billion year-over-year, reflecting a growth of 9.9%[22] - Total liabilities rose to CNY 1.02 billion, compared to CNY 871.13 million in the same period last year, marking an increase of 17.5%[22] - Long-term borrowings increased by 824.43% to CNY 8,244,270, primarily for financing the high-end intelligent medical equipment production base project[8] - The company’s long-term borrowings increased to CNY 92.44 million from CNY 10 million in the previous year, indicating a significant rise in financing activities[22] Cash Flow - Cash flow from operating activities showed a significant decline of 215.39%, resulting in a net outflow of CNY 18,160,569.37[9] - Cash flow from operating activities was CNY 616.17 million, up from CNY 530.10 million in the previous year, indicating a growth of 16.3%[27] - The net cash flow from operating activities was -¥18,160,569.37, a decrease from ¥15,738,938.47 in the previous year[28] - The total cash outflow from operating activities was ¥682,186,847.68, compared to ¥544,380,624.90 in the previous year[28] Research and Development - Research and development expenses increased by 50.75% year-on-year, amounting to CNY 4,740,000[8] - Research and development expenses for Q3 2021 were CNY 47.49 million, a significant increase of 50.7% from CNY 31.50 million in Q3 2020[24] Current Assets - As of September 30, 2021, the company's total current assets amounted to RMB 1,437,054,775.70, an increase from RMB 1,354,549,449.41 at the end of 2020, reflecting a growth of approximately 6.0%[20] - The company's cash and cash equivalents decreased to RMB 146,920,285.60 from RMB 253,042,131.82, representing a decline of about 42.0%[20] - Accounts receivable increased to RMB 372,995,888.06 from RMB 293,492,131.71, marking a rise of approximately 27.1%[20] - Inventory levels rose to RMB 695,837,806.13 from RMB 564,061,407.91, indicating an increase of around 23.4%[20] Equity and Shares - The total equity attributable to shareholders of the parent company was CNY 853.96 million, up from CNY 837.87 million year-over-year, an increase of 1.4%[22] - The company reported a total of 41,131,406 shares under lock-up agreements as of the end of the reporting period, with 6,600,000 shares newly added during the period[14] - The company is in the process of extending the validity period for issuing shares to specific targets, as approved in meetings held on September 29 and October 15, 2021[15] Legal Matters - The company faced a lawsuit regarding a rental contract dispute, with a claim amounting to RMB 244,200, which has since been resolved[18] Fixed and Intangible Assets - The company’s fixed assets were valued at RMB 206,147,605.00, showing a slight decrease from RMB 211,195,126.88 at the end of 2020[20] - The company’s intangible assets were reported at RMB 78,087,521.97, down from RMB 79,933,141.33, reflecting a decrease of approximately 2.3%[20] Audit Status - The company did not undergo an audit for the third quarter report[30]